FFNT — 4Front Ventures Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual income statement for 4Front Ventures, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	19	57.6	105	108	97.4
Cost of Revenue
Gross Profit	8.18	36.5	49.4	51.4	45.9
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Total Operating Expenses	199	85.3	116	123	118
Operating Profit	-180	-27.7	-11.5	-15.3	-20.8
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-178	-44.9	-24.4	-11.2	-37.6
Provision for Income Taxes
Net Income After Taxes	-179	-60	-38.3	-21.3	-44.7
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-182	-47.1	-38.3	-46.9	-91.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-182	-47.1	-38.3	-46.9	-91.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.201	-0.101	-0.053	-0.025	-0.069